Vertical Venture Partners is a venture capital firm investing in enterprise technology companies that target specific vertical markets.
Business Model:
Revenue: $0
Employees: 0-0
Address: Suite 145
City: Menlo Park
State: CA
Zip: 94025
Country: US
Vertical Venture Partners ("VVP") is a venture capital firm investing in enterprise technology companies that target specific vertical markets. VVP focuses on companies with solutions for pain points that are C-suite priorities. Some vertical markets of interest include: Aerospace and Defense, Energy, Financial Services, Healthcare, Insurance, Real Estate, Retail, and Transportation. Some technology areas of interest include: Business Intelligence, Cloud Applications, CRM, Mobile, Security, Software Infrastructure, Instrumentation and Materials Science.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2017 | Grolltex, Inc. | Convertible Note | 700k |
9/2018 | Amira Learning | Seed Round | 3M |
9/2021 | Delix Therapeutics | Series A | 0 |
2/2022 | 1859 | Series A | 0 |
5/2016 | PowWow Mobile | Seed Round | 0 |
9/2015 | Portfolium | Series A | 1.2M |
7/2019 | Nextbite | Series B | 18M |
11/2017 | NanoCellect Biomedical | Series B | 0 |
3/2018 | Redeam | Series A | 7.7M |
12/2021 | ONI | Series B | 75M |
9/2014 | Zipari | Seed Round | 500k |
11/2020 | Ladorian | Series A | 5.9M |
2/2015 | PowWow Mobile | Seed Round | 2.6M |
9/2014 | POWWOW | Series A | 2.5M |
8/2021 | NanoCellect Biomedical | Series D | 0 |
9/2018 | Nextbite | Series A | 9.5M |
1/2018 | NanoCellect Biomedical | Venture Round | 250k |
4/2022 | Concert Health | Series B | 0 |
7/2021 | Inveterate, Inc | Seed Round | 0 |
12/2016 | Menlo Micro | Series A | 0 |
2/2021 | NanoCellect Biomedical | Series C | 0 |
1/2014 | Lanetix | Series A | - |
5/2023 | Inbox Health | Series B | 0 |
1/2020 | Zipari | Series B | 0 |
4/2017 | SOCi | Series A | 8.5M |
4/2021 | Amira Learning | Series B | 11M |
6/2021 | Retina AI | Series A | 8M |
2/2016 | JASK | Seed Round | 2M |
9/2020 | Ionpath | Series B | 0 |
1/2021 | Concert Health | Series A | 0 |
5/2022 | Backflip | Seed Round | 0 |
10/2022 | WhizAI | Series A | 6M |
12/2021 | WhizAI | Series A | 0 |
3/2022 | Menlo Micro | Series C | 0 |
5/2016 | Embroker | Series A | 12.2M |
6/2017 | JASK | Series A | 12M |
7/2020 | Tasso | Series A | 17M |
9/2022 | Roofr | Series A | 12M |
3/2019 | Tasso | Equity | 6.1M |
3/2022 | Gumball | Series A | 0 |
8/2015 | Embroker | Seed Round | 2.2M |
12/2019 | SOCi | Series C | 0 |
8/2018 | SOCi | Series B | 10.5M |
4/2021 | Inbox Health | Series A | 0 |
12/2016 | Zipari | Series A | 7M |
2/2023 | OnSiteIQ | Series A | 10M |
1/2004 | LMIC | Venture Round | 5M |
8/2017 | Amitree | Series A | 7.1M |
11/2016 | Cayke | Seed Round | 500k |
3/2019 | Amitree | Series B | 9.3M |
2/2020 | Intabio | Series B | 18M |
5/2022 | Backflip | Seed Round | 0 |
4/2022 | Concert Health | Series B | 0 |
3/2022 | Menlo Micro | Series C | 0 |
3/2022 | Gumball | Series A | 0 |
2/2022 | 1859 | Series A | 0 |
12/2021 | ONI | Series B | 0 |
12/2021 | WhizAI | Series A | 0 |
9/2021 | Delix Therapeutics | Series A | 0 |
8/2021 | NanoCellect Biomedical | Series D | 0 |
7/2021 | Inveterate, Inc | Seed Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|